Astrocytoma, Grade III (DBCOND0077681)

Identifiers

Synonyms

Grade III Astrocytoma / Anaplastic astrocytoma / Astrocytoma, anaplastic (morphologic abnormality) / Astrocytoma malignant / Astrocytoma malignant NOS

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04757662	Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma	Tadalafil	treatment	1	completed
NCT06614855	A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma	No drug interventions	treatment	1	not_yet_recruiting
NCT03072134	Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma	No drug interventions	treatment	1	completed
NCT06161974	Study of Olutasidenib and Temozolomide in HGG	Olutasidenib Temozolomide	treatment	2	not_yet_recruiting
NCT02644291	Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors	Mebendazole	treatment	1	completed
NCT03224104	Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma	Temozolomide	treatment	1	completed
NCT02722512	Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine	Vitespen	treatment	1	terminated
NCT04304300	Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes	No drug interventions	Not Available	Not Available	recruiting
NCT03956706	Study of Stereotactic Radiosurgery to the Subventricular Zone in Malignant Gliomas	No drug interventions	treatment	Not Available	withdrawn
NCT03596086	HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM	Nalotimagene carmaleucel	treatment	1 / 2	recruiting
NCT03906448	FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma	Temozolomide	treatment	2	terminated
NCT02655601	Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001	BMX-001 free base Temozolomide	treatment	2	active_not_recruiting
NCT05765812	A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma	Temozolomide	treatment	1 / 2	recruiting
NCT03450850	Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma	No drug interventions	treatment	Not Available	active_not_recruiting
NCT06118723	The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)	No drug interventions	Not Available	Not Available	recruiting